Research study Program year 2024 Source: CMS Open Payments

First-in-Human, Phase 1,1b, Open-label, Multicenter Study of Bifunctional EGFR,TGF Fusion Protein BCA101 Monotherapy and in Combination Therapy in Patients with EGFR-Driven Advanced Solid Tumors

Research payments

$13,818,252

36 payments

Through program year 2024, $13,818,252 in research payments was reported against First-in-Human, Phase 1,1b, Open-label, Multicenter Study of Bifunctional EGFR,TGF Fusion Protein BCA101 Monotherapy and in Combination Therapy in Patients with EGFR-Driven Advanced Solid Tumors, across 36 payments, paid by Merck Sharp & Dohme Corporation.

Paid by
Merck Sharp & Dohme Corporation
ClinicalTrials.gov
No trial number was reported for this study

By program year

3 rows
Year Kind Amount Payments
2024 Research $7,210,968 15
2023 Research $5,367,804 13
2022 Research $1,239,480 8

Breakdown

Who paid Research payments · program years 2022–2024
  1. Merck Sharp & Dohme Corporation $13,818,252 36 payments
Who received the money Research payments · program years 2022–2024
  1. Ut Md Anderson Cancer Center Teaching hospital · TX $2,352,354 3 payments
  2. Moffitt Cancer Center Teaching hospital · FL $2,034,960 4 payments
  3. Medical University of South Carolina, Hollings Cancer Center Organisation paid for research $1,378,546 3 payments
  4. University Of Pittsburgh Cancer Institute Cancer Services Organisation paid for research $1,241,230 2 payments
  5. Cleveland Clinic Hospital Teaching hospital · OH $1,210,716 3 payments
  6. Medical University of South Carolina Hollings Cancer Center Organisation paid for research $963,730 1 payment
  7. Ronald Reagan Ucla Teaching hospital · CA $948,332 3 payments
  8. Memorial Sloan Kettering Cancer Center Organisation paid for research $878,904 2 payments
  9. Dana-Farber,Mass General Brigham Cancer Care, Inc. Organisation paid for research $654,664 2 payments
  10. The Regents of The University of California Organisation paid for research $599,864 3 payments

Usually the institution or organisation running the study, not a person.

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record